Invention Grant
- Patent Title: Tetrahydropyridopyrimidines for the treatment and prophylaxis of hepatitis B virus infection
-
Application No.: US16346985Application Date: 2017-11-01
-
Publication No.: US10968217B2Publication Date: 2021-04-06
- Inventor: Zhanling Cheng , Jianhua Wang , Min Wang , Song Yang
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Little Falls
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Little Falls
- Agency: Genentech, Inc.
- Agent Richard G. A. Bone
- Priority: WOPCT/CN2016/104436 20161103
- International Application: PCT/EP2017/077934 WO 20171101
- International Announcement: WO2018/083106 WO 20180511
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/519 ; A61P31/20
Abstract:
The present invention provides novel compounds having the general formula (I) wherein R1, R2 and Z are as described herein, compositions including the compounds and methods of using the compounds.
Public/Granted literature
- US20200062747A1 NOVEL TETRAHYDROPYRIDOPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION Public/Granted day:2020-02-27
Information query
